CO4770973A1 - Quinolinas - Google Patents
QuinolinasInfo
- Publication number
- CO4770973A1 CO4770973A1 CO96059775A CO96059775A CO4770973A1 CO 4770973 A1 CO4770973 A1 CO 4770973A1 CO 96059775 A CO96059775 A CO 96059775A CO 96059775 A CO96059775 A CO 96059775A CO 4770973 A1 CO4770973 A1 CO 4770973A1
- Authority
- CO
- Colombia
- Prior art keywords
- benzo
- quinoline
- pharmaceutically acceptable
- addition salt
- oxide
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Una 8-(benzo[C]tiadiazolil, benzo[C]-furazanil, o 2-metil-2H-benzo[d]triazolil)-quinolina, en forma libre o de N-óxido, o una sal de adición de ácido o una sal de amonio farmacéuticamente aceptable. Un proceso para la producción de un compuesto de conformidad con las reivindicaciones 1, 2 ó 3, caracterizado porque comprende las etapas de hacer reaccionar (i) un 3 -Q- o 4-Q-benzo[c]triazol con una 8-Q´-quinolina, en donde Q y Q´ son grupos salientes capaces de participar en una reacción de acoplamiento cruzado, (ii) de manera opcional, N-alquilar o N-oxidar el producto, y recuperar el compuesto así obtenido en forma libre, de N-óxido o de sal de adición de ácido o de amonio farmacéuticamente aceptable.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9523267.4A GB9523267D0 (en) | 1995-11-14 | 1995-11-14 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CO4770973A1 true CO4770973A1 (es) | 1999-04-30 |
Family
ID=10783856
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CO96059775A CO4770973A1 (es) | 1995-11-14 | 1996-11-13 | Quinolinas |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP0873338A1 (es) |
| JP (1) | JPH11515000A (es) |
| KR (1) | KR19990067574A (es) |
| CN (1) | CN1202170A (es) |
| AU (1) | AU7570996A (es) |
| BR (1) | BR9611504A (es) |
| CA (1) | CA2235126A1 (es) |
| CO (1) | CO4770973A1 (es) |
| CZ (1) | CZ149498A3 (es) |
| GB (1) | GB9523267D0 (es) |
| HU (1) | HUP9903492A3 (es) |
| MX (1) | MX9803839A (es) |
| PE (1) | PE17598A1 (es) |
| PL (1) | PL326636A1 (es) |
| SK (1) | SK63998A3 (es) |
| TR (1) | TR199800851T2 (es) |
| WO (1) | WO1997018208A1 (es) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TR200909479T2 (tr) | 1999-08-21 | 2012-02-21 | Nycomed Gmbh | Sinerjistik kombinasyon. |
| KR20040007596A (ko) | 2001-05-23 | 2004-01-24 | 다나베 세이야꾸 가부시키가이샤 | 골절 치료 촉진용 조성물 |
| KR20040007583A (ko) | 2001-05-23 | 2004-01-24 | 다나베 세이야꾸 가부시키가이샤 | 연골 질환의 재생치료용 조성물 |
| MXPA05010373A (es) | 2003-04-01 | 2005-12-05 | Applied Research Systems | Inhibidores de fosfodiesterasas en infertilidad. |
| WO2005070891A2 (en) * | 2004-01-23 | 2005-08-04 | Amgen Inc | Compounds and methods of use |
| JP2006347936A (ja) * | 2005-06-15 | 2006-12-28 | Bayer Cropscience Ag | 殺虫性ベンズアニリド類 |
| EP2569285A1 (en) | 2010-05-10 | 2013-03-20 | Gilead Sciences, Inc. | Bifunctional quinoline derivatives |
| WO2011143106A1 (en) | 2010-05-10 | 2011-11-17 | Gilead Sciences, Inc. | Bi - functional pyrazolopyridine compounds |
| MY189505A (en) | 2012-10-16 | 2022-02-16 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of roryt |
| ES2628365T3 (es) | 2012-10-16 | 2017-08-02 | Janssen Pharmaceutica N.V. | Moduladores de quinolinilo unidos a fenilo de ROR-GAMA-T |
| ES2619610T3 (es) | 2012-10-16 | 2017-06-26 | Janssen Pharmaceutica Nv | Moduladores de ROR-gamma-t de quinolinilo enlazado con heteroarilo |
| US9284308B2 (en) | 2013-10-15 | 2016-03-15 | Janssen Pharmaceutica Nv | Methylene linked quinolinyl modulators of RORγt |
| US10555941B2 (en) | 2013-10-15 | 2020-02-11 | Janssen Pharmaceutica Nv | Alkyl linked quinolinyl modulators of RORγt |
| CA2927182A1 (en) | 2013-10-15 | 2015-04-23 | Janssen Pharmaceutica Nv | Quinolinyl modulators of ror.gamma.t |
| US9221804B2 (en) | 2013-10-15 | 2015-12-29 | Janssen Pharmaceutica Nv | Secondary alcohol quinolinyl modulators of RORγt |
| US9403816B2 (en) | 2013-10-15 | 2016-08-02 | Janssen Pharmaceutica Nv | Phenyl linked quinolinyl modulators of RORγt |
| WO2015057629A1 (en) | 2013-10-15 | 2015-04-23 | Janssen Pharmaceutica Nv | ALKYL LINKED QUINOLINYL MODULATORS OF RORyt |
| US9328095B2 (en) | 2013-10-15 | 2016-05-03 | Janssen Pharmaceutica Nv | Heteroaryl linked quinolinyl modulators of RORgammat |
| US11427545B2 (en) * | 2018-06-24 | 2022-08-30 | Adama Agan Ltd. | Process for the preparation of Quinmerac |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9027055D0 (en) * | 1990-12-13 | 1991-02-06 | Sandoz Ltd | Organic compounds |
| US5455252A (en) * | 1993-03-31 | 1995-10-03 | Syntex (U.S.A.) Inc. | Optionally substituted 6,8-quinolines |
-
1995
- 1995-11-14 GB GBGB9523267.4A patent/GB9523267D0/en active Pending
-
1996
- 1996-11-12 PE PE1996000810A patent/PE17598A1/es not_active Application Discontinuation
- 1996-11-13 CO CO96059775A patent/CO4770973A1/es unknown
- 1996-11-13 CA CA002235126A patent/CA2235126A1/en not_active Abandoned
- 1996-11-13 AU AU75709/96A patent/AU7570996A/en not_active Abandoned
- 1996-11-13 TR TR1998/00851T patent/TR199800851T2/xx unknown
- 1996-11-13 CN CN96198305A patent/CN1202170A/zh active Pending
- 1996-11-13 WO PCT/EP1996/004978 patent/WO1997018208A1/en not_active Application Discontinuation
- 1996-11-13 EP EP96938196A patent/EP0873338A1/en not_active Withdrawn
- 1996-11-13 HU HU9903492A patent/HUP9903492A3/hu unknown
- 1996-11-13 BR BR9611504A patent/BR9611504A/pt not_active Application Discontinuation
- 1996-11-13 PL PL96326636A patent/PL326636A1/xx unknown
- 1996-11-13 JP JP9515313A patent/JPH11515000A/ja not_active Withdrawn
- 1996-11-13 CZ CZ981494A patent/CZ149498A3/cs unknown
- 1996-11-13 KR KR1019980703597A patent/KR19990067574A/ko not_active Application Discontinuation
- 1996-11-13 SK SK639-98A patent/SK63998A3/sk unknown
-
1998
- 1998-05-14 MX MX9803839A patent/MX9803839A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CZ149498A3 (cs) | 1998-08-12 |
| CA2235126A1 (en) | 1997-05-22 |
| PE17598A1 (es) | 1998-04-06 |
| WO1997018208A1 (en) | 1997-05-22 |
| HUP9903492A2 (en) | 2000-07-28 |
| EP0873338A1 (en) | 1998-10-28 |
| MX9803839A (es) | 1998-09-30 |
| KR19990067574A (ko) | 1999-08-25 |
| JPH11515000A (ja) | 1999-12-21 |
| GB9523267D0 (en) | 1996-01-17 |
| PL326636A1 (en) | 1998-10-12 |
| HUP9903492A3 (en) | 2000-08-28 |
| TR199800851T2 (xx) | 1998-08-21 |
| AU7570996A (en) | 1997-06-05 |
| CN1202170A (zh) | 1998-12-16 |
| SK63998A3 (en) | 1998-10-07 |
| BR9611504A (pt) | 1999-03-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4770973A1 (es) | Quinolinas | |
| CY2119B1 (en) | Tetrazole derivatives of bile acids a process for their production and their use as medicines | |
| MY113274A (en) | Omeprazole magnesium salt form | |
| HUT59558A (en) | New 5-chloro-quinoline-8-oxy-alkane-carboxylic acid derivatives, process for producing and utilizing them as antidotum | |
| PH25156A (en) | Pyrimidine derivatives, process for their production and herbicidal method and compositions | |
| ZA98496B (en) | Process for the production of acetic acid. | |
| PL326322A1 (en) | Ciral methylphenyloxyazolydinones | |
| UA42745C2 (uk) | Спосіб виготовлення таблеток, які містять пароксетин, та таблетка, яка містить пароксетин | |
| HUP9901285A3 (en) | Process for the production of difluoromethane | |
| HUP9700188A3 (en) | Process for producing benzenedicarboxylic acid dichloride | |
| ATE212031T1 (de) | Metallocen-phosphoramidit-konjugate, verfahren zu ihrer herstellung sowie deren verwendung | |
| IL115301A0 (en) | Process for the manufacture of starch products | |
| BR9508280A (pt) | Processo de fabricação de item de aço de alta-intensidade | |
| HUP9801442A3 (en) | Phenyl acetic acid derivatives, process and intermediate products for their production and their use as insecticides, acaricides, nematocides and fungicides | |
| HU9200771D0 (en) | Process for the production of aryl-1,2,4-triazolyn-5-on derivatives | |
| ITMI922692A1 (it) | Medicamenti e preparazioni pure di dicloridrato di melarsomina, processo per il loro ottenimento e prodotti intermedi ottenuti | |
| YU12000A (sh) | Supstituisani 1,2,3,4,5,6-heksahidro-2,6-metano-3-benzazocin -10-oli, postupak za njihovo pripremanje i njihova primena kao lekova | |
| HUT49863A (en) | Process for producing 4-amino-1h-1,2,4-triazol-5-one derivatives | |
| KR0156581B1 (en) | 1,4-benzothiazine-2-acetic acid derivatives and process for production | |
| HUT71793A (en) | 2,4-diamino-3-hydroxy-carboxylic acid derivatives, pharmaceutical compns. contg. them and process for producing the said compds. | |
| PL311002A1 (en) | Method of obtaining aminomethanophosphonic acid | |
| BG105326A (en) | Novel benzoylguanadine derivatives with advantageous properties, method for producing them and their use in the production of medicaments | |
| CA2353680A1 (en) | Process for the production of cyclene | |
| TW347383B (en) | A process for the production of a crystalline sodium salt of amoxicillin in ethanol as solvent | |
| AU1552701A (en) | Process for the production of 5-oxy-7-oxabicyclo-(4.1.0)hept-3-E NE-3-carboxylic acid esters |